Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
Functional Antagonism between NF-κB and Nuclear Receptors: Implications in Carcinogenesis and Strategies for Optimal Cancer Chemopreventive Interventions
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
337-344
Author(s):
V. B. Andela
Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
345-354
Author(s):
Jian Yu Rao and Ning Li
Ferroquine: A New Weapon in the Fight Against Malaria
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
3
Page:
135-147
Author(s):
Christophe Biot
Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists
Journal:
Current Drug Targets - Infectious Disorders
Volume:
4
Page:
103-110
Author(s):
Hirokazu Tamamura and Nobutaka Fujii
Clinical Impact of Gene Expression Profiling on Oncology Diagnosis, Prognosis, and Treatment
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
7
Page:
183-206
Author(s):
Annette S. Kim
The Relation Between the Chemical Structure of Flavonoids and Their Estrogen-Like Activities
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1333-1343
Author(s):
Jacob Vaya and Snait Tamir
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
235-256
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris
Retinoids in Cancer Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
285-298
Author(s):
Masataka Okuno, Soichi Kojima, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Yasutoshi Muto, Scott L. Friedman and Hisataka Moriwaki